Related Experiment Video
Updated: Feb 8, 2026

Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty
Published on: February 27, 2018
Total hip arthroplasty in osteonecrosis secondary to sickle cell disease
Mohamed Zubair Farook1, Moji Awogbade2, Karthik Somasundaram3
1Department of Trauma & Orthopaedics, King's College Hospital NHS Foundation Trust, King's College London, Denmark Hill, London, SE5 9RS, UK.
Insights
Total hip arthroplasty (THA) in sickle cell disease (SCD) patients showed comparable revision rates to general populations. Multidisciplinary care in a specialized sickle cell clinic effectively reduced complications, improving outcomes for these complex cases.
Area of Science:
- Orthopedic Surgery
- Hematology
- Rheumatology
Background:
- Sickle cell disease (SCD) frequently leads to osteonecrosis (ON), a significant cause of joint damage.
- Total hip arthroplasty (THA) in SCD patients presents unique surgical challenges and higher complication risks.
Purpose of the Study:
- To evaluate the outcomes of total hip arthroplasty (THA) in patients with sickle cell disease (SCD).
- To analyze complication rates and identify factors influencing revision surgery in this cohort.
Main Methods:
- Retrospective analysis of 34 THAs performed between 1999 and 2016 in 30 SCD patients.
- Documentation of comorbidities, surgical procedures, and follow-up data, including complications and revision indications.
Main Results:
- The study included 34 THAs in 30 patients (mean age 37 years) with a mean follow-up of 10.5 years.
- Six patients (17.6%) required revision surgery: 2 for prosthetic joint infection (PJI) and 4 for acetabular osteolysis.
- Revision rates were comparable to published literature for non-SCD populations.
Conclusions:
- THA in SCD patients can achieve outcomes comparable to the general population.
- A coordinated, multidisciplinary approach through a combined sickle cell clinic is effective in minimizing morbidity associated with THA in SCD.
Background:
Sickle cell disease (SCD) is a multisystem disease, and the predominant articular manifestation is osteonecrosis (ON). Total hip arthroplasty (THA) is technically challenging, and the complication rates are high. In this retrospective study, we have analysed the outcome of THA in a cohort of patients with SCD at our institution.
Materials And Methods:
We identified 34 THAs between 1999 and 2016 in 30 patients (mean age 37 years) from our SCD database. Co-morbidities, both sickle and non-sickle-related, were documented. Complications and indications for revision surgery were analysed.
Results:
An uncemented prosthesis was predominantly used. The mean follow-up was 10.5 years (range 1-18). Six patients had revision surgery (17.6%), 2 (5.8%) for Prosthetic Joint Infection (PJI), and 4 (11.7%) for osteolysis of the acetabular component.
Conclusion:
Our revision rates were comparable to the published literature. Our combined sickle cell clinic and the coordinated multidisciplinary management have been successful in reducing morbidity.
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
Primary and Secondary Growth in Roots and Shoots
Secondary Healthcare System
Secondary Distribution
In residential areas, 120/240 V single-phase, three-wire service is commonly used for lighting, outlets, and large appliances. Urban areas with high-density loads...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

